IL17A and arthritic joint disease: Our previous studies [18], [24] demonstrated that immunization using GPI peptide induced IL-17-producing CD4+ T cells while blockade of IL-17 resulted in amelioration of arthritis, suggesting that IL-17-producing CD4+ T cells play a pathogenic role in GPI peptide-induced arthritis.